A271980 Stock Overview
Jeil Pharmaceutical Co.,Ltd develops and supplies pharmaceutical products primarily in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Jeil Pharmaceutical Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩16,310.00 |
| 52 Week High | ₩22,800.00 |
| 52 Week Low | ₩14,540.00 |
| Beta | 1.14 |
| 1 Month Change | -1.98% |
| 3 Month Change | -0.61% |
| 1 Year Change | -17.67% |
| 3 Year Change | -63.67% |
| 5 Year Change | -62.29% |
| Change since IPO | -65.30% |
Recent News & Updates
Is Jeil PharmaceuticalLtd (KRX:271980) Using Too Much Debt?
Apr 11
Solid Earnings May Not Tell The Whole Story For Jeil PharmaceuticalLtd (KRX:271980)
Mar 19Shareholder Returns
| A271980 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 1.3% | -2.5% | -1.6% |
| 1Y | -17.7% | 0.09% | 2.1% |
Return vs Industry: A271980 underperformed the KR Pharmaceuticals industry which returned 0.1% over the past year.
Return vs Market: A271980 underperformed the KR Market which returned 2.1% over the past year.
Price Volatility
| A271980 volatility | |
|---|---|
| A271980 Average Weekly Movement | 5.3% |
| Pharmaceuticals Industry Average Movement | 4.7% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 11.9% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A271980 has not had significant price volatility in the past 3 months.
Volatility Over Time: A271980's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1959 | 964 | n/a | www.jeilpharm.co.kr |
Jeil Pharmaceutical Co.,Ltd develops and supplies pharmaceutical products primarily in South Korea. It provides products in the areas of antibiotic, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamine. The company also exports its products to approximately 40 countries in ASEAN, Central and South America, Africa, and internationally.
Jeil Pharmaceutical Co.,Ltd Fundamentals Summary
| A271980 fundamental statistics | |
|---|---|
| Market cap | ₩242.91b |
| Earnings (TTM) | ₩5.00b |
| Revenue (TTM) | ₩726.39b |
47.5x
P/E Ratio0.3x
P/S RatioIs A271980 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A271980 income statement (TTM) | |
|---|---|
| Revenue | ₩726.39b |
| Cost of Revenue | ₩542.14b |
| Gross Profit | ₩184.26b |
| Other Expenses | ₩179.25b |
| Earnings | ₩5.00b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 343.46 |
| Gross Margin | 25.37% |
| Net Profit Margin | 0.69% |
| Debt/Equity Ratio | 37.9% |
How did A271980 perform over the long term?
See historical performance and comparison